COVID-19 in patients with B cell immune deficiency

This article aims to describe the clinical manifestations and management of COVID-19 in patients with primary and secondary B cell deficient states. We describe the epidemiologic and clinical features as well as unique management paradigm including isolation precautions with COVID-19. We then focus...

Descripción completa

Detalles Bibliográficos
Autores principales: Vergidis, Paschalis, Levy, Emily R., Ristagno, Elizabeth H., Iyer, Vivek N., O'Horo, John C., Joshi, Avni Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450485/
https://www.ncbi.nlm.nih.gov/pubmed/36087764
http://dx.doi.org/10.1016/j.jim.2022.113351
Descripción
Sumario:This article aims to describe the clinical manifestations and management of COVID-19 in patients with primary and secondary B cell deficient states. We describe the epidemiologic and clinical features as well as unique management paradigm including isolation precautions with COVID-19. We then focus upon primary and secondary preventive approaches including vaccination and pre- as well as post-exposure prophylaxis. Further, we elaborate upon the important disease specific risk factors in these patients and the need to conduct prospective clinical trials to develop individualized management strategies in this population.

Ejemplares similares